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Abstract 
Removing middle molecular weight uremic toxin remains as one of the most 
challenging tasks in hemodialysis. Hence, in this study a high performance 
polysulfone (PSf) hemodialysis membrane was developed by incorporating iron 
oxide (Fe2O3) nanoparticles. The PSf/Fe2O3 hemodialysis membrane and pristine 
PSf membrane were prepared via dry-wet spinning process. The membranes were 
characterized by scanning electron microscopy, water contact angle, average pore 
size, and porosity measurements. The biocompatibility profiles of the membranes 
were also evaluated in terms of protein adsorption and blood coagulation time. 
Next, the performance of the membranes was determined by measuring pure water 
permeability (PWP), bovine serum albumin rejection, and removal of various 
solutes such as urea and lysozyme. The incorporation of Fe2O3 resulted in 
significant increment of the PWP from 40.74 L/m2/h/bar to 58.6 L/m2/h/bar, mainly 
due to the improved water transport properties of the membrane. Moreover, the 
percent removal of urea and lysozyme was reported to be 75.1% and 35.6%, 
respectively. PSf/Fe2O3 hemodialysis membrane is proven to have a bright 
prospect for enhanced blood purification process. 
Keywords: Iron oxide nanoparticles, middle molecular weight uremic toxin, 
hemodialysis membrane, polysulfone membrane 




The number of chronic kidney disease (CKD) patients has 
increased drastically from year to year. One of t he prevalent 
treatments for CK D is hemodialysis. In h emodialysis, the most 
important component that governs the quality of the treatment is 
called dialyzer, where ten thousand of hollow fiber membrane are 
situated. The membranes are usually made up of s ynthetic polymers 
such as polysulfone (PSf) and polyethersulfone (PES) [1,2]. However, 
the membrane surface hydrophobicity and low removal of m iddle 
molecular uremic toxin are among the issues currently faced in 
hemodialysis application [3]. Studies showed that larger uremic toxins 
are difficult to be removed by diffusion. The accumulation of these 
middle molecular weight uremic toxins may lead to the formation of 
amyloid, an abnormal protein that deposits on i nternal organs and 
causes organ failure [4]. Apart from that, the hydrophobic nature of 
the membrane would promote protein loss via adsorption on the 
membrane surface [5]. 
To address the mentioned problems, additives that have excellent 
biocompatibility were added to form a membrane with high 
permeability and surface hydrophilicity. The high permeability can 
actually improve convective separation of m iddle molecule uremic 
toxins, whereas the surface hydrophilicity can minimize the 
interaction between membrane surface and hydrophobic proteins [6]. 
Incorporation of inorganic nanomaterials in membrane matrix has 
become an emerging trend to enhance the membrane permeability, 
selectivity, and physicochemical properties. The recent progress in the 
development of hemodialysis membrane involved the uses of carbon 
nanotubes (CNTs) and graphene [7,8], where the membranes showed 
excellent water transport properties and uremic toxin removal 
compared to that of pristine polymeric membrane.  
Nevertheless, the use of other potential nanomaterials like metal 
oxide in hemodialysis membrane and their potency to improve the 
dialysis performance have never been reported before. Iron o xide 
(Fe2O3) nanoparticles are among the unique metal oxide nanoparticles 
due to their nanoscale dimension, chemical inertness, good 
hydrophilicity, and remarkable total surface area [9,10]. The Fe2O3 
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nano-structure behaves as a good l iquid transport medium, thus 
producing membranes with good interconnectivity and porosity which 
could facilitate water movement across the membrane at minimal 
operating pressure. The presence of t he hydrophilic Fe2O3 at the 
membrane surface could minimize the amount of protein adsorbed on 
the membrane. Additionally, in biomedical applications, Fe2O3 are 
known to be biocompatible and non-toxic [11]. Thus, they have a 
great potential for incorporation in hemodialysis membrane.  
In our previous study, we have investigated the impacts of Fe2O3
addition on membrane liquid separation characteristics and antifouling 
resistance [12], where the nanocomposite membrane was more 
superior compared to the pristine PSf membrane. A particle stabilizer 
known as citric acid (CA) was utilized to improve Fe2O3 dispersion 
stability during membrane fabrication. In a following work [13], the 
optimum weight ratio of F e2O3 and CA was determined to be 1:20. 
Here, the main objective of this work is to study the effects of Fe2O3
addition as membrane nanofillers on he modialysis separation 
performance, focusing on m iddle molecular weight uremic toxin 
removal. Pristine PSf membrane, which is commonly regarded as 
hemodialysis membrane was used as a reference. The morphological 
and surface properties of t he two membranes were compared. The 
biocompatibility profile of the fabricated membranes was also 
evaluated in terms of protein adsorption and blood coagulation time. 
In addition to urea separation, the clearance of lysozyme which 
represents the middle molecular weight toxin was also determined in 





The reagent-grade chemicals were used. PSf polymer was 
purchased from Solvay Advanced Polymers; PVP-K90, CA, human 
serum albumin (HSA), bovine serum albumin (BSA), sodium dodecyl 
sulfate (SDS), urea, and lysozyme were purchased from Sigma-
Aldrich; and Fe2O3 was purchased from Nova Scientific; N-methyl-2-
pyrrolidone (NMP, 99.5 %) and glycerol were supplied from Merck. 
Calcium chloride, Actin FS, and Thromborel S were procured from 
Siemens; BCATM protein assay reagent kit was purchased from 
Thermo Scientific, while QuantiChromTM urea assay kit was obtained 
from BioAssay Systems; phosphate buffer saline (PBS) was a product 
of Amresco.  
Fabrication of PSf/Fe2O3 hollow fiber membrane 
The PSf pellets were pre-dried in oven before use. PVP was 
dissolved in NMP at 70 °C  by mechanical stirring. Next, CA was 
added and blended for 30  min. Then, Fe2O3 was mixed and the 
solution was stirred for 2 h to obtain a homogeneous mixture. Finally, 
PSf was added into the solution with continuous stirring for 24 h. The 
dope solution compositions for t he pristine PSf and PSf/ Fe2O3 
membranes are shown in Table 1. The dope solutions were degassed 
to remove air bubbles. Dry-wet spinning technique was used for the 
fabrication of the hollow fiber membranes. The air gap was fixed at 
50 cm. The membrane dope solution was extruded from a spinneret 
with an inner/outer diameter of 0.4/0.8 mm at a speed of 1 m L/min. 
The bore fluid flow rate of 1 mL/min was streamed into the spinneret 
needle by a constant-flow syringe pump. The collection drum speed of 
10 m/min was used to collect the hollow fiber membranes. The 
fabricated hollow fiber membranes were immersed in water for two 
days and treated in 10 wt% glycerol for one day.  
 
 
Table 1  Dope solution compositions (wt%) of pristine PSf and 
PSf/Fe2O3 membranes. 
Membrane PSf PVP Fe2O3 CA NMP 
Pristine PSf 18.0 4.8 - - 77.2 
PSf/Fe2O3 18.0 4.8 0.1 2.0 75.0 
Characterization of the membranes 
The membrane morphologies were observed using scanning 
electron microscopy (SEM, Hitachi TM3000). The contact angle 
analysis was conducted to determine the membrane hydrophilicity 
using contact angle goniometer from Dataphysics, United States of 
America. Membrane porosity and average pore size were measured 
using methods described by Abidin et al. [3]. 
 
Biocompatibility assessment 
HSA was chosen as model protein for adsorption test.  The 1 cm2
membrane sample was pre-immersed in PBS for 12 h,  followed by 
incubation in 2 mL of 1 m g/mL protein solution for 2 h.  The sample 
was then rinsed with PBS solution and water to eliminate excess 
protein. SDS was then used to extract the protein from membrane 
surface. Protein amount adsorbed on membrane sample was measured 
using BCATM protein assay reagent kit. 
The membranes biocompatibility was further evaluated by 
determining blood clotting time. Around 10 mL of fresh human blood 
was withdrawn and stored in the 2.7 mL vacutainer tubes that contain 
sodium citrate. The blood was centrifuged at 3500 rpm for 15 min to 
obtain PPP. The test was performed using a semi-automated blood 
coagulation analyzer (Sysmex, CA-104) to measure the activated 
partial thromboplastin time (APTT) and prothrombin time (PT). These 
parameters show the time taken before the blood coagulates once it is 
exposed to surrounding or for eign materials. Membrane sample (3 
pieces x 0. 5 cm x 0.5 cm) was immersed in PBS solution for 1 h  
before the incubation in platelet poor pl asma (PPP). Next, the 
membrane was incubated in 0.5 mL of PPP for 30 m in. To measure 
the APTT, 50 µ L of t he incubated PPP was mixed with 50 µL of 
Actin FS and incubated for 180 s econds. 50 µL of calcium chloride, 
CaCl2 was then added and the clotting time was taken. For PT test, 50 
µL of PPP was added into the cuvette and incubated for 60 seconds. 
Next, 100 µL of Thromborel S was mixed and the clotting time was 
taken. 
Separation performance experiment 
Membrane module (25.0 cm x 1.3 cm) was made consisting of 60 
fibers, potted using epoxy glue with both ends cut open. The module 
was equipped with 2 s ets of i nlet and outlet connected to feed and 
dialysate containers.  
The membrane pure water permeability (PWP) and BSA rejection 
were first performed as both represent the ultrafiltration capacity of 
the membrane and its ability to retain albumin in blood. The PWP of 
the fabricated membranes was measured at a TMP of 0. 7 bar using 
Eq. (1) 
 
PWP (L/m2 h bar) = (V/ A× t × △ △P)                                                
(1)                                                                 
where V is the volume of permeate (L), A is the effective surface area 
(m2), t is the permeation time (h), and △ △P is the TMP. The percent 
rejection was calculated using following Eq. (2) 
 
Rejection (%)= (1-Cp /Cf ) × 100                                                        (2) 
 
where Cp and Cf are the BSA concentrations of permeate and feed, 
respectively. The concentration of BSA was measured using UV-vis 
spectrophotometer (Hach DR 5000TM). 
The prepared module was equilibrated with pure water for 
overnight and pressurized with water at 1 ba r for at least 30 min 
before the experiments. The feed tank was filled with a mixture of 
solutes containing urea (1500 ppm) and lysozyme (40 ppm) in water, 
while dialysate tank was filled with water. The feed flow rate was 
fixed at 15 mL/min, while dialysate was fixed at the flow rate of 37.5 
mL/min. The experiment was conducted for 4 h and the sample was 
collected every 1 h. The concentration of samples was measured using 
UV-vis spectrophotometer where the urea concentration was 
identified using QuantiChromTM urea assay kit. The amount of toxins 
removed from feed solution was defined as percent clearance, which 
was calculated using Eq. (1) 
 
Clearance (%)  = (1- Cf  /Ci ) × 100                                                   (3) 
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where Ci and Cf are the initial and final concentrations of the solute in 
feed solution (mg/L), respectively.  
 
RESULTS AND DISCUSSION 
Morphology of the fabricated membranes 
FESEM images of the pristine PSf and PSf/Fe2O3 membranes are 
shown in Fig. 1. The membranes produced common asymmetric 
structure which consists of a dense skin layer and a porous sub layer. 
The porous sublayer extends from the compact like structure along the 
finger-like macrovoids and ends with sponge-like macropores. The 
permeation rate depends on t he skin layer thickness. The porous 
sublayer mainly acts as a mechanical support of t he membrane that 
prevent it from collapsing.  
The PSf/Fe2O3 membrane exhibited more finger-like structures 
than the PSf membrane due to faster phase inversion process. The 
thinner skin layer was also formed due to the presence of Fe2O3 which 
induced the instantaneous phase inversion as soon as the PSf/Fe2O3 
dope solution gets in contact with water.  
The analysis was continued with the observation on the membrane 
outer morphological surface. It can be seen that the pore distribution 
on the membrane surface has increased in size due to free movement 
of Fe2O3, CA, and PVP molecules near the membrane-moisture 
interface. Besides, the CA and PVP tend to diffuse out of the solvent 
and move into the water bath during phase inversion process, leaving 
empty spaces in the nascent hollow fibers [14].  
 
 
Fig. 1 The FESEM images of (a) pristine PSf and (b) PSf/Fe2O3
membranes showing (i) cross-section and (ii) outer surface. 
Water contact angle, porosity, and average pore size of 
membranes 
      Contact angle is known as a first indication of t he interaction 
between the water, protein, and the membrane surface. By improving 
membrane hydrophilicity, the interaction between membrane and 
albumin will be weakened. Eventually, the membrane has better 
chance of re jecting albumin and reducing the tendency of pro tein 
fouling. Meanwhile, membrane porosity should be as high as possible 
to enable high transmembrane flux. The results of water contact angle, 
porosity, and average pore size are shown in Table 2. The 
incorporation of Fe2O3 resulted in substantial increase of the 
PSf/Fe2O3 membrane surface hydrophilicity, where hydrophilic Fe2O3
migrated spontaneously to membrane or w ater interface to reduce 
their surface energy. On top of that, the membrane hydrophilicity was 
improved due to the presence oxygen species in the Fe2O3, allowing 






Table 2  Contact angle, porosity, and average pore size of pristine PSf 
and PSf/Fe2O3 membranes (n=3). 
Membrane Contact 
angle (°) 
Porosity (%) Pore Size 
(nm) 
Pristine PSf 66.81 ± 0.21 43.29 ± 0.11 63.51 ± 0.07 
PSf/ Fe2O3 55.20 ± 0.16 67.36 ± 0.18 38.84 ± 0.12 
 
As shown in Table 2, the PSf/Fe2O3 membrane is more porous 
compared to the pristine PSf membrane. The increase in the number 
and size of finger-like structures has enhanced the membrane porosity. 
Nevertheless, the average pore size of the membrane became smaller 
after the addition of F e2O3, most probably due to the rapid 
precipitation of polymer at the membrane skin layer. The smaller 
average pore size may permit only uremic toxins to pass through the 
membrane, while preventing large proteins like albumin from crossing 
the membrane.  
 
Biocompatibility of the membrane 
In hemodialysis treatment, the membrane must be biocompatible. 
The PSf/Fe2O3 and pristine PSf membranes were assessed in terms of 
protein adsorption and blood coagulation time. Protein adsorption 
contributes to health complication after hemodialysis by causing 
protein depletion in blood. Besides, the adsorbed protein molecules on 
membrane surface during hemodialysis treatment can activate the 
blood coagulation cascade thus causing biofouling. The results of 
HSA adsorption are shown in Table 3. 
The PSf/Fe2O3 membrane adsorbed less HSA compared to the 
pristine PSf membrane. Generally, hydrophilic membranes have a 
lower tendency to adsorb proteins compared to hydrophobic 
membranes. This has been proven by several studies, confirming that 
the amount of adsorbed protein per unit area of membrane decreased 
with increasing surface hydrophilicity of membrane [15].  
 
Table 3  Protein adsorption results of the PSf/Fe2O3 and pristine PSf 
membranes (n=3). 
Membrane HSA adsorption (µg/cm2) 
Pristine PSf 8.23 ± 1.13 
PSf/Fe2O3 6.68 ± 0.71 
 
Blood coagulation is among the fatal problems that can occur 
during hemodialysis treatment. This problem is usually caused by the 
interaction of b lood with blood-incompatible materials. Membrane 
with poor bl ood-compatibility may induce the blood to clot rapidly 
and be deposited on t he membrane surface. The clotting of bl ood 
promotes excessive loss of blood, which poses health risk on the CKD 
patients especially those who suffer from anemia. Therefore, it is 
important to maintain the normal range of bl ood coagulation time 
when the blood is in contact with membrane surface. APTT and PT 
are the established measurements used to predict the intrinsic pathway 
and the bioactivity of blood coagulation factors [1]. 
The results of APTT and PT of t he pristine PSf and PSf/Fe2O3
membranes compared to the control sample are shown in Fig. 2. The 
membranes fall within the normal range value, in which the PSf/Fe2O3 
membrane prolonged the APTT and PT value as compared to the 
pristine PSf membrane. The findings proved that the materials used to 
produce the membrane was compatible since the membrane did not 
speed up the blood coagulation time excessively.  
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Fig. 2 Blood clotting time of the control, pristine PSf and PSf/Fe2O3
membranes (n=3). 
PWP and BSA rejection 
The results of PWP and BSA rejection of the pristine PSf 
membrane and the PSf/Fe2O3 membrane are shown in Table 3. The 
PSf/Fe2O3 membrane expressed better PWP which could be attributed 
to its increased porosity and surface hydrophilicity, which vitally 
enhanced the membrane’s water transport properties. The role of the 
high surface area Fe2O3 embedded in membrane matrix was to 
accommodate and facilitate more water molecules. On top of that, the 
PSf/Fe2O3 membrane morphologies which comprised of more finger-
like structures and well-distributed pores promoted more water 
passages through the membranes compared to the pristine PSf 
membrane.  
The BSA (~67 kDa) separation experiment was conducted to 
determine the amount of albumin that can be retained in blood during 
hemodialysis treatment. This study showed that the BSA rejection of 
the PSf/Fe2O3 membrane was higher compared to the pristine PSf 
membrane. This was due to improved route of water molecules to pass 
through, leaving the large and hydrophobic BSA molecules behind. 
As the water moved faster, the BSA had a lesser tendency of getting 
close to the hydrophilic membrane surface. The recorded BSA 
rejection certainly exceeded most results reported in literature which 
were below than 97 % [7,16].  
 
Table 3 PWP and BSA rejection of the pristine PSf and PSf/Fe2O3
membranes. 
Membrane PWP (L/m2h bar) Rejection   
(%) 
Pristine PSf 40.7 91.2 
PSf/ Fe2O3 58.6 98.1 
 
Urea and lysozyme separation 
The results of urea and lysozyme clearance are displayed in Fig. 3 
and Fig. 4, respectively. Urea is known as the classical marker for 
uremic toxins, where it is used to define the quality of hemodialysis 
membrane. A similar trend was observed on t he two membranes, 
where the urea diffusion took place at the highest rate in the first one 
hour before it got slower. 
The PSf/Fe2O3 membrane showed better urea removal rate 
compared to the pristine PSf membrane. The higher water retention 
capacity of PSf/Fe2O3 membrane due to higher porosity eased the urea 
diffusion process by drawing dialysate to fill in the membrane wall 
faster. In general, the urea clearance achieved the minimum 
requirement set by the Ministry of Health Malaysia (>65 %). Besides, 
the value was higher compared to previously published hemodialysis 
membranes like heparin-immobilized poly (lactic) acid membrane (74 
%) by Goa et al. [16] and MWCNTs-incorporated PES membrane (56 
%) by Irfan et al. [7]. 
 
 
Fig. 3 The results of urea percent clearance for pristine PSf and 
PSf/Fe2O3 membranes over 4 h of operation (n=3). 
Meanwhile, a s teady reduction of lysozyme concentration in the 
feed solution was achieved by both membranes. The PSf/Fe2O3 
displayed a superior performance over the pristine PSf membrane 
with lysozyme clearance of 35.6 %. Having a good transport property 
has influenced the PSf/Fe2O3 to obtain the better separation, as middle 
molecules removal can be improved using high flux and porous 
membranes. The lysozyme, dissolved in water, was carried along with 
water via convection and passed through the membrane, following a 
hydrostatic pressure gradient. 
From this study, the lysozyme percent clearance marked a better 
value compared to the previous studies by Gao et al. [16] and Irfan et 
al. [7] which were 18 % and 28 %, respectively. 
 
Fig. 4  The results of lysozyme percent clearance for pristine PSf and 
PSf/Fe2O3 membranes over 4 h of operation (n=3). 
CONCLUSION 
 
The effects of F e2O3 incorporation on t he hemodialysis 
membrane morphology, surface property, and separation performance 
were studied. The PSf/Fe2O3 membrane was confirmed to be more 
hydrophilic and had a highly porous structure with better pore 
distribution compared to the pristine PSf membrane. The PSf/Fe2O3 
membrane was more biocompatible, proved by the lesser HSA 
adsorption and normal blood coagulation time. The PSf/Fe2O3 
membrane achieved PWP of 58. 6 L/m2 h bar and BSA rejection of 
98.1 %, while achieving excellent separation performance of urea 
(75.1 %) and lysozyme (35.6 %). Overall, the results showed that the 
PSf/Fe2O3 membrane is an outstanding candidate for hemodialysis 
treatment since it could retain almost all albumin while showing high 
percent clearance of urea and lysozyme. 
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